Search for: "WATSON PHARMACEUTICALS, INC."
Results 181 - 200
of 224
Sorted by Relevance
|
Sort by Date
19 Mar 2016, 10:13 am
Watson Pharms., Inc., 707 F.3d 1330, 1336 (Fed. [read post]
27 Sep 2010, 12:59 am
District Court for the District of Columbia challenging FDA’s September 14th approval of Watson Laboratories, Inc. [read post]
23 Nov 2010, 2:19 am
Watson Pharmaceuticals, Inc., D2010-0800 (WIPO August 31, 2010). [read post]
3 Jun 2010, 5:35 am
– In re Ciprofloxacin Antitrust Litigation (PatLit) Circumvent PCV and Porcilis PCV vaccines – US: Wyeth files patent infringement suit against Intervet based on their manufacture of PCV vaccines (Patent Docs) Copegus (Ribavirin) – US: Ascio seeks declaratory judgment of unenforceability, invalidity and non-infringement of Three Rivers’ patent based on ANDA filing (Patent Docs) Entocort (Budesonide) – US: AstraZeneca settles Entocort patent suit with Teva, stipulates… [read post]
15 May 2011, 2:54 pm
LLC, Watson Pharmaceuticals, Inc., and Synthon Holding B.V. notifying them that the Bureau believes the companies violated federal law by failing to inform antitrust authorities about patent agreements involving Sanofi’s insomnia drug AMBIEN CR (zolpidem tartrate) Tablets, but that instead of recommending that the FTC take enforcement action, it would issue advisory letters. [read post]
23 Sep 2010, 12:39 pm
District Court for the District of Columbia challenging FDA’s September 14th approval of Watson Laboratories, Inc. [read post]
19 Feb 2024, 12:55 pm
Watson, 188 F. [read post]
14 Jul 2010, 7:53 am
Watson Pharmaceuticals, Inc., 211 F.3d 21 (2d Cir. 2000). [read post]
1 Dec 2011, 3:58 am
Ranbaxy's Lipitor-copy goes on sale 1 Dec 2011, but the impact on consumers is a bit more complicated than one might think.For example, Watson Pharmaceuticals is selling a Lipitor copy under an agreement made with patentee Pfizer (thus, an authorized generic). [read post]
8 Feb 2011, 10:51 pm
(FDA Law Blog) US: Another academic with solutions to problems that don’t exist (Patent Docs) US: Syngenta files for declaratory judgment of invalidity and non-infringement of Bayer’s patents based on its development of GM crops containing HPPD gene (Patent Docs) US: District Court New Jersey: Loss of market share to infringing competitor during six year reexamination warrants denial of stay: Wyeth et al v Abbott (Docket Report) US: District Court New Jersey: Court precludes jury… [read post]
16 Jul 2012, 1:32 pm
Wyeth Pharmaceuticals, Inc., 2012 WL 724794, at *3 (D.S.C. [read post]
15 Nov 2013, 11:34 am
Watson v. [read post]
15 Feb 2011, 4:57 pm
©2011 Amaxx Risk Solutions, Inc. [read post]
5 May 2014, 8:28 am
This prompted an Actavis subsidiary, Watson Laboratories, Inc., to file suit against the U.S. [read post]
24 Jun 2013, 6:08 am
Watson Pharmaceuticals, Inc. [5] Citing FTC v. [read post]
24 Jun 2013, 10:08 am
Watson Pharmaceuticals, Inc. [5] Citing FTC v. [read post]
19 Jan 2011, 3:23 pm
©2010 Amaxx Risk Solutions, Inc. [read post]
4 May 2011, 7:52 am
Generic Opioid Products Generic Name Drug Name Applicant/Sponsors Fentanyl Fentanyl Extended Release Transdermal System Actavis Fentanyl Fentanyl Extended Release Transdermal System Lavipharm Labs Fentanyl Fentanyl Extended Release Transdermal System Mylan Technologies Fentanyl Fentanyl Extended Release Transdermal System Teva Pharms Fentanyl Fentanyl Extended Release Transdermal System Watson … [read post]
2 May 2013, 2:22 am
FITZPATRICK, INC." [read post]
19 Mar 2012, 1:31 am
Wyeth, Inc., No. 09-cv-0854 (W.D. [read post]
